In CV disease, clopidogrel reduces nonfatal MI and MACE vs. aspirin but not stroke or mortality.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 36469913.
- Also identified by DOI 10.7326/J22-0094.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tasoudis PT, Kyriakoulis IG, Sagris D, et al. <b>Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis.</b> Thromb Haemost. 2022;122:1879-87. 35577054.
Medical subject headings
- Cardiovascular Diseases
- Stroke